Elastase-Activated Antimicrobial Peptide for a Safer Pulmonary Treatment of Cystic Fibrosis Infections
As bioactive small proteins with antimicrobial and immunomodulatory activities that are naturally produced by all living organisms, antimicrobial peptides (AMPs) have a marked potential as next-generation antibiotics. However, their development as antibacterial agents is limited by low stability and...
Saved in:
Main Authors: | Margherita Degasperi (Author), Riccardo Sgarra (Author), Mario Mardirossian (Author), Sabrina Pacor (Author), Massimo Maschio (Author), Marco Scocchi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cathelicidins-a rich seam of antimicrobial peptides waiting for exploitation
by: Alessandro Tossi, et al.
Published: (2024) -
Drug Management of Antimicrobial Peptide Production in Cystic Fibrosis in Children
by: O.Ye. Abaturov, et al.
Published: (2016) -
Glycosaminoglycans as Multifunctional Anti-Elastase and Anti-Inflammatory Drugs in Cystic Fibrosis Lung Disease
by: Judith A. Voynow, et al.
Published: (2020) -
Vibrating Mesh Nebulisation of Pro-Antimicrobial Peptides for Use in Cystic Fibrosis
by: Éanna Forde, et al.
Published: (2019) -
In Vitro Inhibition of Neutrophil Elastase Activity by Inhaled Anti-Pseudomonas Antibiotics Used in Cystic Fibrosis Patients
by: Andreas Hector, et al.
Published: (2010)